Christopher Durant Turner - Jan 6, 2023 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Medical Officer
Signature
/s/ Deborah Ann Miller, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Jan 6, 2023
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 03:47 PM
Previous filing
May 19, 2022
Next filing
Jun 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Award $0 +144K $0.00 144K Jan 6, 2023 Class A Common Stock 144K $27.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over the next four years in equal monthly installments following January 6, 2023, subject to continued service to Nuvalent, Inc. through the applicable vesting date.